U.S. Pen Needles Market Size, Share & Trends Analysis Report By Product (Standard & Safety Pen Needles), By Needle Length (4mm, 5mm, 10mm, 12mm), By Therapy (Insulin, Glucagon-like-Peptide-1), And Segment Forecasts, 2024 - 2030

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                    1.2. Segment Definitions
                        1.2.1. Product
                        1.2.2. Needle Length
                        1.2.3. Therapy
                        1.2.4. Estimates and forecasts timeline
                    1.3. Research Methodology
                    1.4. Information Procurement
                        1.4.1. Purchased database
                        1.4.2. GVR’s internal database
                        1.4.3. Secondary sources
                        1.4.4. Primary research
                        1.4.5. Details of primary research
                            1.4.5.1. Data for primary interviews in U.S.
                    1.5. Information or Data Analysis
                        1.5.1. Data analysis models
                    1.6. Market Formulation & Validation
                    1.7. Model Details
                        1.7.1. Commodity flow analysis (Model 1)
                        1.7.2. Approach 1: Commodity flow approach
                    1.8. List of Secondary Sources
                    1.9. List of Primary Sources
                    1.10. Objectives
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Outlook
                        2.2.1. Product Outlook
                        2.2.2. Needle Length Outlook
                        2.2.3. Therapy Outlook
                    2.3. Competitive Insights
Chapter 3. U.S. Pen Needles Market Variables, Trends & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent market outlook
                        3.1.2. Related/ancillary market outlook
                    3.2. Market Dynamics
                        3.2.1. Market Driver Analysis
                            3.2.1.1. Growing prevalence of diabetes
                            3.2.1.2. Technological advancements
                        3.2.2. Market Restraint Analysis
                            3.2.2.1. Preference for alternative drug delivery method
                            3.2.2.2. Lack of skilled professionals
                    3.3. U.S. Pen Needles Market Analysis Tools
                        3.3.1. Industry Analysis - Porter’s Five Forces
                            3.3.1.1. Supplier power
                            3.3.1.2. Buyer power
                            3.3.1.3. Substitution threat
                            3.3.1.4. Threat of new entrant
                            3.3.1.5. Competitive rivalry
                        3.3.2. PESTEL Analysis
                            3.3.2.1. Political landscape
                            3.3.2.2. Technological landscape
                            3.3.2.3. Economic landscape
Chapter 4. U.S. Pen Needles Market: Product Estimates & Trend Analysis
                    4.1. U.S. Pen Needles Market: Product Dashboard
                    4.2. U.S. Pen Needles Market: Product Movement Analysis
                    4.3. U.S. Pen Needles Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                    4.4. Standard Pen Needles
                        4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    4.5. Safety Pen Needles
                        4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. U.S. Pen Needles Market: Needle Length Estimates & Trend Analysis
                    5.1. U.S. Pen Needles Market: Needle Length Dashboard
                    5.2. U.S. Pen Needles Market: Needle Length Movement Analysis
                    5.3. U.S. Pen Needles Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                    5.4. 4 mm
                        5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    5.5. 5 mm
                        5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    5.6. 6 mm
                        5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    5.7. 8 mm
                        5.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    5.8. 10 mm
                        5.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    5.9. 12 mm
                        5.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. U.S. Pen Needles Market: Therapy Estimates & Trend Analysis
                    6.1. U.S. Pen Needles Market: Therapy Dashboard
                    6.2. U.S. Pen Needles Market: Therapy Movement Analysis
                    6.3. U.S. Pen Needles Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                    6.4. Insulin
                        6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    6.5. Glucagon-like-Peptide-1 (GLP-1)
                        6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    6.6. Growth Hormone
                        6.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Competitive Landscape
                    7.1. Recent Developments & Impact Analysis, By Key Market Participants
                    7.2. Company/Competition Categorization
                    7.3. Vendor Landscape
                        7.3.1. List of key distributors and channel partners
                        7.3.2. Key customers
                        7.3.3. Key company market share analysis, 2023
                        7.3.4. Novo Nordisk A/S
                            7.3.4.1. Company Overview
                            7.3.4.2. Financial performance
                            7.3.4.3. Product benchmarking
                            7.3.4.4. Strategic initiatives
                        7.3.5. Becton
                            7.3.5.1. Company overview
                            7.3.5.2. Financial performance
                            7.3.5.3. Product benchmarking
                            7.3.5.4. Strategic initiatives
                        7.3.6. Dickinson and Company
                            7.3.6.1. Company overview
                            7.3.6.2. Financial performance
                            7.3.6.3. Product benchmarking
                            7.3.6.4. Strategic initiatives
                        7.3.7. Terumo Corp.
                            7.3.7.1. Company overview
                            7.3.7.2. Financial performance
                            7.3.7.3. Product benchmarking
                            7.3.7.4. Strategic initiatives
                        7.3.8. Owen Mumford Ltd.
                            7.3.8.1. Company overview
                            7.3.8.2. Financial performance
                            7.3.8.3. Product benchmarking
                            7.3.8.4. Strategic initiatives
                        7.3.9. Ypsomed
                            7.3.9.1. Company overview
                            7.3.9.2. Financial performance
                            7.3.9.3. Product benchmarking
                            7.3.9.4. Strategic initiatives
                        7.3.10. B. Braun Melsungen AG
                            7.3.10.1. Company overview
                            7.3.10.2. Financial performance
                            7.3.10.3. Product benchmarking
                            7.3.10.4. Strategic initiatives
                        7.3.11. HTL-STREFA
                            7.3.11.1. Company overview
                            7.3.11.2. Financial performance
                            7.3.11.3. Product benchmarking
                            7.3.11.4. Strategic initiatives
                        7.3.12. UltiMed, Inc.
                            7.3.12.1. Company overview
                            7.3.12.2. Financial performance
                            7.3.12.3. Product benchmarking
                            7.3.12.4. Strategic initiatives
                        7.3.13. Allison Medical, Inc.
                            7.3.13.1. Company overview
                            7.3.13.2. Financial performance
                            7.3.13.3. Product benchmarking
                            7.3.13.4. Strategic initiatives
                        7.3.14. Artsana S.p.A.
                            7.3.14.1. Company overview
                            7.3.14.2. Financial performance
                            7.3.14.3. Product benchmarking
                            7.3.14.4. Strategic initiatives

List of Tables

Table 1 List of abbreviations
Table 2 U.S. Pen Needles Market, by Product, 2018 - 2030 (USD Million)
Table 3 U.S. Pen Needles Market, by Needle Length, 2018 - 2030 (USD Million)
Table 4 U.S. Pen Needles Market, by Therapy, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 U.S. pen needles market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 QFD modelling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 End-use and end-use segment snapshot
Fig. 10 Sales channel and age segment snapshot
Fig. 11 Competitive landscape snapshot
Fig. 12 Market dynamics
Fig. 13 Porter’s Five Forces analysis
Fig. 14 PESTLE analysis
Fig. 15 U.S. pen needles market: Product outlook and key takeaways
Fig. 16 U.S. pen needles market: Product movement analysis
Fig. 17 Standard pen needles market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 18 Safety pen needles market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 19 U.S. pen needles market: Needle length outlook and key takeaways
Fig. 20 U.S. pen needles market: Needle length movement analysis
Fig. 21 4 mm market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 5 mm market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 6 mm market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 8 mm market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 10 mm market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 12 mm market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 U.S. pen needles market: Therapy outlook and key takeaways
Fig. 28 U.S. pen needles market: Therapy movement analysis
Fig. 29 Insulin market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Glucagon-like-Peptide-1 (GLP-1) market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 Growth hormone market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 Company market share analysis, 2023
Fig. 33 Strategic Framework